Bioinspired imidazo[1,2-a:4,5-c']dipyridines with dual antiproliferative and anti-migrative properties in human cancer cells: The SAR investigation
- Eur J Med Chem. 2021 Jun 5:218:113258. doi: 10.1016/j.ejmech.2021.113258.
- 1. University of Tours, Faculty of Pharmacy, EA 7502 SIMBA, 31 Avenue Monge, 37200, Tours, France; University of Gezira, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, P.O box 20, Gezira, Sudan.
- 2. University of Tours, INSERM, UMR 1069 N2C, 10 boulevard Tonnellé, 37032, Tours Cedex, France.
- 3. University of Tours, Faculty of Pharmacy, EA 7502 SIMBA, 31 Avenue Monge, 37200, Tours, France.
- 4. University of Tours, EA 4245 T2I, 10 boulevard Tonnellé, 37032, Tours Cedex, France.
- 5. University of Khartoum, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Khartoum, Sudan; Jouf University, College of Pharmacy, Department of Pharmaceutical Chemistry, Saudi Arabia.
- 6. University of Tours, EA 4245 T2I, 10 boulevard Tonnellé, 37032, Tours Cedex, France; Institut Universitaire de France, 75006, Paris, France. Electronic address: [email protected].
- 7. University of Tours, Faculty of Pharmacy, EA 7502 SIMBA, 31 Avenue Monge, 37200, Tours, France. Electronic address: [email protected].
Herein, we report the design, synthesis and evaluation of novel bioinspired imidazo[1,2-a:4,5c']dipyridines. The structural optimization identified four anti-proliferative compounds. Compounds 11, 18, 19 and 20 exhibited excellent Anticancer activities in vitro with IC50 of 0.4-5 μM against three human Cancer cell lines (MDA-MB-468, MDA-MB-435s and MDA-MB-231). These four compounds induced Apoptosis in MDA-MB-231 cells in a dose-dependent manner, targeting different apoptotic proteins expression: 11 increased the expression of pro-apoptotic Bax protein while 18-20 reduced the level of anti-apoptotic Bcl-2 protein. Compounds 18 and 19 also reduced MDA-MB-231 cells proliferation as measured by Ki-67 staining. Furthermore, compounds were also tested for the ability to inhibit cell migration in the highly aggressive human MDA-MB-435s cell line. Six compounds of this series (8, 15, 18, 22, 23, 24) inhibited cell migration by 41-50% while four compounds (20, 25, 27, 30) inhibited the migration by 53-62% in wound-healing experiments. Interestingly, compound 20 presented both antiproliferative and anti-migration activities and might be a promising anti-metastatic agent for Cancer treatment.